IMVT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

23.17

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

0.04

EPS Last/This Y

0.19

EPS This/Next Y

0.2

Price

34.13

Target Price

44.6

Analyst Recom

1.62

Performance Q

25.55

Upside

-205.4%

Beta

0.74

Ticker: IMVT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	IMVT	28.91	0.15	0.24	30522
2026-04-24	IMVT	28.55	0.15	0.00	30507
2026-04-27	IMVT	28.62	0.15	0.02	30556
2026-04-28	IMVT	26.97	0.15	0.51	30578
2026-04-29	IMVT	26.96	0.19	0.06	35571
2026-04-30	IMVT	27.14	0.19	0.43	35784
2026-05-01	IMVT	27.13	0.19	0.10	35796
2026-05-04	IMVT	27.85	0.19	0.00	36575
2026-05-05	IMVT	27.83	0.18	0.17	38242
2026-05-06	IMVT	28.69	0.18	0.13	38296
2026-05-07	IMVT	27.23	0.18	0.00	38417
2026-05-08	IMVT	28.97	0.17	0.02	39518
2026-05-11	IMVT	29.08	0.17	0.25	39741
2026-05-12	IMVT	28.65	0.17	0.00	39753
2026-05-13	IMVT	29.24	0.17	0.13	40346
2026-05-14	IMVT	28.99	0.17	0.54	39904
2026-05-15	IMVT	27.5	0.17	0.07	39404
2026-05-18	IMVT	26.53	0.05	0.05	22489
2026-05-19	IMVT	26.3	0.05	0.06	22933
2026-05-20	IMVT	35.55	0.05	0.55	23286
2026-05-21	IMVT	34.16	0.27	0.31	27935
2026-05-22	IMVT	34.13	0.32	0.26	27397
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	IMVT	28.89	3.4	-33.3	-2.53
2026-04-24	IMVT	28.59	3.4	-27.2	-2.53
2026-04-27	IMVT	28.63	3.4	-27.9	-2.53
2026-04-28	IMVT	26.97	3.4	6.0	-2.53
2026-04-29	IMVT	26.96	3.4	6.3	-2.53
2026-04-30	IMVT	27.16	3.4	2.3	-2.53
2026-05-01	IMVT	27.11	3.4	3.3	-2.53
2026-05-04	IMVT	27.87	3.4	-12.3	-2.53
2026-05-05	IMVT	27.84	3.4	-11.8	-2.53
2026-05-06	IMVT	28.67	3.4	-29.1	-2.53
2026-05-07	IMVT	27.23	3.4	0.7	-2.53
2026-05-08	IMVT	28.96	3.4	-34.7	-2.53
2026-05-11	IMVT	29.07	3.4	-36.9	-2.53
2026-05-12	IMVT	28.61	3.4	-27.6	-2.53
2026-05-13	IMVT	29.24	1.9	-40.5	-2.53
2026-05-14	IMVT	28.98	1.9	-35.1	-2.53
2026-05-15	IMVT	27.49	1.9	-4.6	-2.53
2026-05-18	IMVT	26.55	1.9	14.7	-2.53
2026-05-19	IMVT	26.29	1.9	0.9	-2.53
2026-05-20	IMVT	35.51	1.9	-168.9	-2.53
2026-05-21	IMVT	34.15	1.9	-147.2	-2.53
2026-05-22	IMVT	34.13	-	-	-2.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	IMVT	16.08	5.70	22.20
2026-04-24	IMVT	15.89	5.70	22.20
2026-04-27	IMVT	15.90	5.91	23.49
2026-04-28	IMVT	15.90	5.91	23.49
2026-04-29	IMVT	15.90	5.91	23.49
2026-04-30	IMVT	15.90	5.91	23.49
2026-05-01	IMVT	15.90	5.91	23.48
2026-05-04	IMVT	15.90	5.75	23.48
2026-05-05	IMVT	15.90	5.75	23.48
2026-05-06	IMVT	15.90	5.75	23.48
2026-05-07	IMVT	15.90	5.75	23.48
2026-05-08	IMVT	15.90	5.75	23.48
2026-05-11	IMVT	15.90	6.38	23.48
2026-05-12	IMVT	15.90	6.38	22.38
2026-05-13	IMVT	15.90	6.38	22.38
2026-05-14	IMVT	15.90	6.38	22.38
2026-05-15	IMVT	15.90	6.38	22.38
2026-05-18	IMVT	15.90	6.39	22.38
2026-05-19	IMVT	15.90	6.39	22.38
2026-05-20	IMVT	15.90	6.39	22.38
2026-05-21	IMVT	15.89	6.39	22.38
2026-05-22	IMVT	15.75	6.39	23.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.67

Avg. EPS Est. Current Quarter

-0.62

Avg. EPS Est. Next Quarter

-0.63

Insider Transactions

15.75

Institutional Transactions

6.39

Beta

0.74

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.1

Max Drawdown 5-Year %

-78.3

Target Price

44.6

P/E

Forward P/E

PEG

P/S

P/B

8.17

P/Free Cash Flow

EPS

-2.77

Average EPS Est. Cur. Y

-2.58

EPS Next Y. (Est.)

-2.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.97

Return on Equity vs Sector %

-86.4

Return on Equity vs Industry %

-70.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ IMVT Healthcare

$34.15

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

6/25

Volume

4/15

Valuation

8/20

TP/AR

2/10

Options

8/10

RSI

66.7

Range 1M

80.5%

Sup Dist

4.3%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

15/25

Growth

6/30

Estimates

2/20

Inst/Vol

10/15

Options

8/10

EPS Yr

7.7%

EPS NY

2.3%

52W%

90.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +30.6% upside

Quality

2/30

Valuation

8/30

Growth

3/25

Stability

7/10

LT Trend

4/5

Upside

+30.6%

Quality

Immunovant, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 315

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

IMVT

Latest News

—

Caricamento notizie per IMVT…

stock quote shares IMVT – Immunovant Inc Stock Price stock today

news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch IMVT – Immunovant Inc yahoo finance google finance

stock history IMVT – Immunovant Inc invest stock market

stock prices IMVT premarket after hours

ticker IMVT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMVT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y